ConductScience.org, home

Paper41998294

Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics.

Liu Y and 3 others. Apoptosis, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics. Papers, record 41998294. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41998294

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Programmed cell death in lung cancer: mechanisms, immune responses, and therapeutics.
PubMed
Journal
Apoptosis
PubMed
Year
2026
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-07-18
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Liu YYang
2Chen QQingxin
3Xu JJiayu
4Chi HHao

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Lung NeoplasmsMajor topic
ApoptosisMajor topic
Humans
Pyroptosis
Ferroptosis
Immunotherapy
Necroptosis
Animals
Tumor Microenvironment

Source PubMed

Download CSV of topics

References323

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
138269375
Gender differences, environmental pressures, tumor characteristics, and death rate in a lung cancer cohort: a seven-years Bayesian survival analysis using cancer registry data from a contaminated area in Italy.
Front Public Health2023https://conductscience.org/library/papers/38269375PubMed
237479810The global burden of lung cancer: current status and future trends.Nat Rev Clin Oncol2023https://conductscience.org/library/papers/37479810PubMed
338357203Case report: A lung squamous cell carcinoma patient with a rare EGFR G719X mutation and high PD-L1 expression showed a good response to anti-PD1 therapy.Front Oncol2024https://conductscience.org/library/papers/38357203PubMed
431454018Systemic Therapy for Locally Advanced and Metastatic Non-Small Cell Lung Cancer: A Review.JAMA2019https://conductscience.org/library/papers/31454018PubMed
531691957Biomarkers for immune checkpoint inhibition in non-small cell lung cancer (NSCLC).Cancer2020https://conductscience.org/library/papers/31691957PubMed
635288298Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: Perspectives for immunotherapy of SCLC.Semin Cancer Biol2022https://conductscience.org/library/papers/35288298PubMed
734742351The role of ferroptosis in lung cancer.Biomark Res2021https://conductscience.org/library/papers/34742351PubMed
829362479Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018.Cell Death Differ2018https://conductscience.org/library/papers/29362479PubMed
925236395Essential versus accessory aspects of cell death: recommendations of the NCCD 2015.Cell Death Differ2015https://conductscience.org/library/papers/25236395PubMed
1035963853Regulated cell death (RCD) in cancer: key pathways and targeted therapies.Signal Transduct Target Ther2022https://conductscience.org/library/papers/35963853PubMed
1137550363The therapeutic potential of targeting regulated non-apoptotic cell death.Nat Rev Drug Discov2023https://conductscience.org/library/papers/37550363PubMed
1236612290The Association between Baseline Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Chemotherapy: A Systematic Review with Network Meta-Analysis.Cancers (Basel)2022https://conductscience.org/library/papers/36612290PubMed
1338753784DNA damage induces p53-independent apoptosis through ribosome stalling.Science2024https://conductscience.org/library/papers/38753784PubMed
1435650427Drugging the efferocytosis process: concepts and opportunities.Nat Rev Drug Discov2022https://conductscience.org/library/papers/35650427PubMed
1532873928Emerging connectivity of programmed cell death pathways and its physiological implications.Nat Rev Mol Cell Biol2020https://conductscience.org/library/papers/32873928PubMed
1631100266The Coming Decade of Cell Death Research: Five Riddles.Cell2019https://conductscience.org/library/papers/31100266PubMed
1735432318Programmed Cell Death Tunes Tumor Immunity.Front Immunol2022https://conductscience.org/library/papers/35432318PubMed
1833785842Necroptosis, pyroptosis and apoptosis: an intricate game of cell death.Cell Mol Immunol2021https://conductscience.org/library/papers/33785842PubMed
1932778143Ferroptosis, necroptosis, and pyroptosis in anticancer immunity.J Hematol Oncol2020https://conductscience.org/library/papers/32778143PubMed
2028764929Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma.Gastroenterology2017https://conductscience.org/library/papers/28764929PubMed

See all 323 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
42504199Machine learning prioritization identifies PANX1 as an inflammation-associated candidate regulator in lung adenocarcinoma.Front Genet2026https://conductscience.org/library/papers/42504199

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41998294

GET https://conductscience.org/api/papers/v1/41998294/references?page=2